Article

Early changes in gene expression profiles in AML patients during induction chemotherapy

2022-06-08

Abstract excerpt

<h4>Background: </h4> Elucidation of the genetic mechanisms underlying treatment response to standard induction chemotherapy in AML patients is warranted, in order to aid in risk-adapted treatment decisions as novel treatments are emerging. In this pilot study, we explored the treatment-induced expression patterns in a small cohort of AML patients by analyzing differential gene expression (DGE) over the first two...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 679e78c7-f3fa-5e27-8345-d323b1ee9c8e
DOI: 10.21203/rs.3.rs-643327/v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Early changes in gene expression profiles in AML patients during induction chemotherapyDOI 10.21203/rs.3.rs-643327/v3Read

Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures.Semantic proximity Read

RNA Expression of Genes Involved in Cytarabine Metabolism and Transport Predicts Cytarabine Response in Acute Myeloid LeukemiaSemantic proximity Read

Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.Semantic proximity Read

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cellsSemantic proximity Read

Early response evaluation by single cell signaling profiling in acute myeloid leukemiaSemantic proximity Read

Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.Semantic proximity Read

SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study.Semantic proximity Read

Inhibition of NF-κB Signaling Alters Acute Myelogenous Leukemia Cell TranscriptomicsSemantic proximity Read

Aldehyde Dehydrogenase Genes as Prospective Actionable Targets in Acute Myeloid LeukemiaSemantic proximity Read

A Distinct p53 Protein Isoform Signature Reflects the Onset of Induction Chemotherapy for Acute Myeloid LeukemiaSemantic proximity Read

Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation.Semantic proximity Read

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposideSemantic proximity Read